Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
it is a GLP-1 receptor agonist that mimics a natural hormone to help regulate appetite and blood sugar
Wish the price was more accessible for longer use
Body Composition Individuals with higher body fat percentages may experience a slower onset of effects compared to those with lower body fat, as the medication interacts with body systems differently
GoodGirlRx is a technology platform and does not compound medications
May 02, 2025, 14:27 ET Novo Nordisk hopes to expand Wegovy label by becoming the first GLP-1 treatment for obesity in a pill The FDA filing is based on the results of the phase 3 OASIS 4 trial that evaluated oral semaglutide 25 mg in adults with obesity or overweight 1 Novo Nordisk continues to build on 100-year-plus legacy of science and innovation PLAINSBORO, N.J., May 2, 2025 /PRNewswire/ -- Today, Novo Nordisk announced that the U.S
US$ 25.19
US$ 28.96
US$ 27.95
US$ 27.10
